Levocetirizine Dihydrochloride
23 NDCs across 14 manufacturers|23 Generic,0 Brand
Levocetirizine Dihydrochloride is used to treat rhinitis, allergic, perennial, rhinitis, allergic, seasonal and urticaria, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 25, 2007, and the first generic was approved Nov 26, 2010. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $28 million on Levocetirizine Dihydrochloride across 2.3 million claims for 712,000 beneficiaries.
Levocetirizine Dihydrochloride is available as 23 NDCs from 14 manufacturers (23 generic, 0 brand), with NADAC prices from $0.05 to $0.24 per EA — the most expensive product costs about 4.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
23
23G / 0B
Manufacturers
14
competing in market
Price Spread
$0.05 – $0.24
per EA, 20 of 23 NDCs
7d Activity
avg -0.9% WoW · of 23 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Camber Consumer Care manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Histamine-1 Receptor Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
14 manufacturers producing LEVOCETIRIZINE DIHYDROCHLORIDE
Frequently Asked Questions
What is Levocetirizine Dihydrochloride used to treat?
Levocetirizine Dihydrochloride is used to treat rhinitis, allergic, perennial, rhinitis, allergic, seasonal and urticaria, per the National Library of Medicine's MED-RT classification.
When did Levocetirizine Dihydrochloride become available as a generic?
FDA approved the first generic Levocetirizine Dihydrochloride (ANDA) on Nov 26, 2010. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Levocetirizine Dihydrochloride?
In 2024, Medicare Part D spent $28 million on Levocetirizine Dihydrochloride across 2.3 million claims for 712,000 beneficiaries.
How many Levocetirizine Dihydrochloride products are on the market?
The Levocetirizine Dihydrochloride drug market contains 23 NDCs from 14 manufacturers — 23 generic and 0 brand products.
What is the price range for Levocetirizine Dihydrochloride?
NADAC reference prices for Levocetirizine Dihydrochloride range from $0.0511 to $0.2355 per EA — the most expensive product costs about 4.6× the cheapest. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Levocetirizine Dihydrochloride?
14 manufacturers list Levocetirizine Dihydrochloride in NADAC. Ranked by number of NDCs, the largest are Camber Consumer Care (4), Dr. Reddy's Laboratories Inc. (3), AmerisourceBergen (2), Cardinal Health (2), Camber Pharmaceuticals Inc. (2).
How has the price of Levocetirizine Dihydrochloride changed recently?
Over the past 7 days, 3 Levocetirizine Dihydrochloride NDCs rose and 16 fell, with a market-wide average change of -0.9%.